Theravance Biopharma, Inc. Earnings Per Share, Basic and Diluted
Theravance Biopharma, Inc. (TBPH) reported Earnings Per Share, Basic and Diluted of -$0.80 per share for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-05.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-08-05
- Theravance Biopharma, Inc. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.80.
- Theravance Biopharma, Inc. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$1.24.
- Theravance Biopharma, Inc. earnings per share, basic and diluted for the quarter ending 2020-12-31 was -$0.92.
- Theravance Biopharma, Inc. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$1.16.
- Theravance Biopharma, Inc. earnings per share, basic and diluted for fiscal 2020 was -$4.46.
- Theravance Biopharma, Inc. earnings per share, basic and diluted for fiscal 2019 was -$4.25.
- Theravance Biopharma, Inc. earnings per share, basic and diluted for fiscal 2018 was -$3.99.
- Theravance Biopharma, Inc. earnings per share, basic and diluted for fiscal 2017 was -$5.45.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-06-30 | -$0.80 10-Q · filed 2021-08-05 | -$2.03 10-Q · filed 2021-08-05 | ||
| 2021-03-31 | -$1.24 10-Q · filed 2021-05-06 | |||
| 2020-12-31 | -$0.92 10-K · filed 2021-02-26 | -$4.46 10-K · filed 2021-02-26 | ||
| 2020-09-30 | -$1.16 10-K · filed 2021-02-26 | -$3.55 10-Q · filed 2020-11-09 | ||
| 2020-06-30 | -$1.00 10-Q · filed 2021-08-05 | -$2.39 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | -$1.40 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | -$1.17 10-K · filed 2021-02-26 | -$4.25 10-K · filed 2021-02-26 | ||
| 2019-09-30 | -$1.05 10-K · filed 2021-02-26 | -$3.08 10-Q · filed 2020-11-09 | ||
| 2019-06-30 | -$0.72 10-K · filed 2021-02-26 | -$2.04 10-Q · filed 2020-08-10 | ||
| 2019-03-31 | -$1.32 10-K · filed 2021-02-26 | |||
| 2018-12-31 | -$0.92 10-K · filed 2020-02-27 | -$3.99 10-K · filed 2021-02-26 | ||
| 2018-09-30 | -$1.10 10-K · filed 2020-02-27 | -$3.07 10-Q · filed 2019-11-08 | ||
| 2018-06-30 | -$0.76 10-K · filed 2020-02-27 | -$1.98 10-Q · filed 2019-08-05 | ||
| 2018-03-31 | -$1.22 10-K · filed 2020-02-27 | |||
| 2017-12-31 | -$1.64 10-K · filed 2019-02-28 | -$5.45 10-K · filed 2020-02-27 | ||
| 2017-09-30 | -$1.27 10-K · filed 2019-02-28 | -$3.80 10-Q · filed 2018-11-08 | ||
| 2017-06-30 | -$1.27 10-K · filed 2019-02-28 | -$2.53 10-Q · filed 2018-08-02 | ||
| 2017-03-31 | -$1.27 10-K · filed 2019-02-28 | |||
| 2016-12-31 | -$1.36 10-K · filed 2018-02-28 | -$4.26 10-K · filed 2019-02-28 | ||
| 2016-09-30 | -$0.73 10-K · filed 2018-02-28 | -$2.86 10-Q · filed 2017-11-08 | ||
| 2016-06-30 | -$1.06 10-K · filed 2018-02-28 | -$2.16 10-Q · filed 2017-08-09 | ||
| 2016-03-31 | -$1.10 10-K · filed 2018-02-28 | |||
| 2015-12-31 | -$1.23 10-K · filed 2017-03-01 | -$5.34 10-K · filed 2018-02-28 | ||
| 2015-09-30 | -$1.40 10-K · filed 2017-03-01 | -$4.12 10-Q · filed 2016-11-09 | ||
| 2015-06-30 | -$1.42 10-K · filed 2017-03-01 | -$2.71 10-Q · filed 2016-08-09 | ||
| 2015-03-31 | -$1.29 10-K · filed 2017-03-01 | |||
| 2014-12-31 | -$2.02 10-K · filed 2016-03-11 | -$7.46 10-K · filed 2017-03-01 | ||
| 2014-09-30 | -$1.72 10-K · filed 2016-03-11 | -$5.44 10-Q · filed 2015-11-12 | ||
| 2014-06-30 | -$1.83 10-K · filed 2016-03-11 | -$3.72 10-Q · filed 2015-08-13 | ||
| 2014-03-31 | -$1.89 10-K · filed 2016-03-11 | |||
| 2013-12-31 | -$1.39 10-K · filed 2015-03-13 | -$4.92 10-K · filed 2016-03-11 | ||
| 2013-09-30 | -$1.29 10-K · filed 2015-03-13 | -$3.53 10-Q · filed 2014-11-12 | ||
| 2013-06-30 | -$1.23 10-K · filed 2015-03-13 | -$2.24 10-Q · filed 2014-08-14 | ||
| 2013-03-31 | -$1.01 10-K · filed 2015-03-13 | |||
| 2012-12-31 | -$0.30 10-K · filed 2015-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |